These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Serum α-linolenic and other ω-3 fatty acids, and risk of disabling dementia: Community-based nested case-control study. Yamagishi K; Ikeda A; Chei CL; Noda H; Umesawa M; Cui R; Muraki I; Ohira T; Imano H; Sankai T; Okada T; Tanigawa T; Kitamura A; Kiyama M; Iso H; Clin Nutr; 2017 Jun; 36(3):793-797. PubMed ID: 27265182 [TBL] [Abstract][Full Text] [Related]
7. Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study. Eriksdotter M; Vedin I; Falahati F; Freund-Levi Y; Hjorth E; Faxen-Irving G; Wahlund LO; Schultzberg M; Basun H; Cederholm T; Palmblad J J Alzheimers Dis; 2015; 48(3):805-12. PubMed ID: 26402079 [TBL] [Abstract][Full Text] [Related]
8. Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study. Zuliani G; Cavalieri M; Galvani M; Volpato S; Cherubini A; Bandinelli S; Corsi AM; Lauretani F; Guralnik JM; Fellin R; Ferrucci L J Gerontol A Biol Sci Med Sci; 2010 May; 65(5):559-64. PubMed ID: 20299544 [TBL] [Abstract][Full Text] [Related]
9. Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy. De Ronchi D; Berardi D; Menchetti M; Ferrari G; Serretti A; Dalmonte E; Fratiglioni L Dement Geriatr Cogn Disord; 2005; 19(2-3):97-105. PubMed ID: 15591799 [TBL] [Abstract][Full Text] [Related]
10. Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparison of individuals with and without cognitive impairment and Alzheimer's disease. Phillips MA; Childs CE; Calder PC; Rogers PJ Nutr Neurosci; 2012 Nov; 15(6):271-7. PubMed ID: 22824373 [TBL] [Abstract][Full Text] [Related]
11. Uric acid and dementia in community-dwelling older persons. Ruggiero C; Cherubini A; Lauretani F; Bandinelli S; Maggio M; Di Iorio A; Zuliani G; Dragonas C; Senin U; Ferrucci L Dement Geriatr Cogn Disord; 2009; 27(4):382-9. PubMed ID: 19339776 [TBL] [Abstract][Full Text] [Related]
12. [Use of the Mini-Cog test as a screening method for dementia in the Italian population: the Argento Study results]. Michieletto F; Binkin N; Saugo M; Boorson S; Scanlan J; Ig Sanita Pubbl; 2006; 62(2):159-72. PubMed ID: 17206187 [TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of (n-3) highly unsaturated fatty acids are good biomarkers of relative dietary fatty acid intakes: a cross-sectional study. Kuriki K; Nagaya T; Tokudome Y; Imaeda N; Fujiwara N; Sato J; Goto C; Ikeda M; Maki S; Tajima K; Tokudome S J Nutr; 2003 Nov; 133(11):3643-50. PubMed ID: 14608088 [TBL] [Abstract][Full Text] [Related]
14. Absolute versus relative measures of plasma fatty acids and health outcomes: example of phospholipid omega-3 and omega-6 fatty acids and all-cause mortality in women. Miura K; Hughes MCB; Ungerer JPJ; Smith DD; Green AC Eur J Nutr; 2018 Mar; 57(2):713-722. PubMed ID: 27995316 [TBL] [Abstract][Full Text] [Related]
15. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test. Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291 [TBL] [Abstract][Full Text] [Related]
16. Omega-6 and omega-3 fatty acids predict accelerated decline of peripheral nerve function in older persons. Lauretani F; Bandinelli S; Bartali B; Cherubini A; Iorio AD; Blè A; Giacomini V; Corsi AM; Guralnik JM; Ferrucci L Eur J Neurol; 2007 Jul; 14(7):801-8. PubMed ID: 17594339 [TBL] [Abstract][Full Text] [Related]
17. [The estimation of premorbid intelligence levels in French speakers]. Mackinnon A; Mulligan R Encephale; 2005; 31(1 Pt 1):31-43. PubMed ID: 15971638 [TBL] [Abstract][Full Text] [Related]
18. Association of inflammatory biomarkers with depressive symptoms and cognitive decline in a community-dwelling healthy older sample: a 3-year follow-up study. Matsushima J; Kawashima T; Nabeta H; Imamura Y; Watanabe I; Mizoguchi Y; Kojima N; Yamada S; Monji A J Affect Disord; 2015 Mar; 173():9-14. PubMed ID: 25462389 [TBL] [Abstract][Full Text] [Related]